Advertisement

Topics

Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 7 Major Markets 20152025 [Updated: 16092015] Prices from USD $6100

11:03 EDT 21 Jun 2017 | BioPortfolio Reports

Black Swan Analysis Epiomic Epidemiology Series Forecast Report on Dry Eye Syndrome in 7 Major Markets
Dry Eye Syndrome is a disorder of the tear film which is caused by Aqueous Tear Deficiency ATD insufficient tear production or by Meibomian Gland Dysfunction MGD excessive tear evaporation, or in some cases patients have both conditions. Inflammation of the ocular surface and the lachrymal glands are observed in patients. This report provides the current prevalent population for Dry Eye Syndrome across 7 Major Markets USA, France, Germany, Italy, Spain, UK and Japan split by gender and 5year age cohort. Along with the current prevalence, the report provides an overview of the types, occlusion locations and the prevalence of associated disorders of Dry Eye Syndrome. The report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.
Providing a valueadded level of insight from the analysis team at Black Swan, several of the main symptoms and comorbidities of Dry Eye Syndrome have been quantified and presented alongside the overall prevalence figures. These subpopulations within the main disease are also included at a country level across the 10year forecast snapshot.
Main symptoms and comorbidities for Dry Eye Syndrome include:
Glaucoma
Diabetes
Hypertension
Rheumatoid Arthritis
Sjorgen's Syndrome
Dry Mouth
This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.
Reason to buy
Able to quantify patient populations in global Dry Eye Syndrome's market to target the development of future products, pricing strategies and launch plans.
Gain further insight into the prevalence of the subdivided types of Dry Eye Syndrome and identify patient segments with high potential.
Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
Provide a level of understanding on the impact from specific comorbid conditions on Dry Eye Syndrome's prevalent population.
Identify subpopulations within Dry Eye Syndrome which require treatment.
Gain an understanding of the specific markets that have the largest number of Dry Eye Syndrome patients.

Original Article: Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 7 Major Markets 20152025 [Updated: 16092015] Prices from USD $6100

NEXT ARTICLE

More From BioPortfolio on "Epiomic Epidemiology Series: Dry Eye Syndrome Forecast in 7 Major Markets 20152025 [Updated: 16092015] Prices from USD $6100"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pulmonary Hypertension
Pulmonary arterial hypertension (PAH) is a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs of affected individuals. Symptoms can range from mild breathles...